Rosuvafix-F — Rosuvastatin & Fenofibrate Tablets I.P.

SCHEDULE H — Rx Only. Not to be sold without the prescription of a Registered Medical Practitioner.

Dosage Form

Film Coated Tablets

Packaging

10×10 Tablets

Cardiac

Rosuvafix-F

Dual-Action Dyslipidaemia Control

Composition

Rosuvastatin & Fenofibrate Tablets I.P.

  • Rosuvastatin Calcium I.P. eq. to Rosuvastatin 10 mg
  • Fenofibrate I.P. 160 mg
  • Excipients q.s.
  • Colour: Titanium Dioxide I.P.

Indications for Use

  • Mixed dyslipidaemia (elevated LDL + triglycerides)
  • Hypertriglyceridaemia
  • Combined management of cholesterol & lipids
  • Patients uncontrolled on monotherapy

Key Benefits

  • Dual mechanism — statin + fibrate in one tablet
  • Simultaneously lowers LDL-C and triglycerides
  • Raises protective HDL cholesterol
  • Single-pill combination improves adherence
  • Clinically proven for mixed dyslipidaemia